top of page

Innovative biobanking for everyone

By sending an email, you agree to the processing of personal data.

Sign up and be the first to know!

Sign up and be the first to know!

The future of prevention is here. For everyone.

Innovative biobanking BloodCloud™ enables everyone to prepare for the arrival of personalized predictive medicine.

How does BloodCloud™ work?

The most important
is a question of the near future

The prerequisite for fully utilizing the potential of your BloodCloud™ archive is the introduction of new methods into diagnostic practice and at the same time at least 3 collected samples from which time-lapse data can be obtained.

*min. number of CryoCapsule™ for implementation

Currently available analyses

We are already able to offer advanced diagnostic methods. Some are available in plans
when taking a sample, you need it for others
consecutive year data for comparison.

1x a year

1x a year

01/2024

Individual 
sample library

Each of your samples is stored in the BloodCloud™ repository. The more extensive your archive, the more valuable the data.

Regular 
biobanking

Periodic collection of venous blood and its cryopreservation in a certified storage facility.

The most important aspect
is a question of the near future

Comprehensive prediction of health development

The non-targeted metabolomic method allows us to analyse thousands of parameters in a single sample. Through batch analysis of at least three CryoCapsules™ from your BloodCloud™ archive, you will get all the data you need for detailed, reliable and accurate predictive analysis of the development of your health condition.

In this way, you will recognize health risks that can be easily avoided with early prevention.

*

Soon

*min. number of CryoCapsules™ required

The prerequisite for fully utilizing the potential of your BloodCloud™ archive is the introduction of new methods into diagnostic practice and at the same time at least 3 collected samples from which time-lapse data can be obtained.

Cholesterol
HDL cholesterol
LDL cholesterol
non-HDL cholesterol
Triacylglycerols
Atherogenic index

Lipid metabolism, risk of heart and vascular disease

PREMIUM
OPTIMAL

Leukocytes 
Erythrocytes 
Hemoglobin

Platelets

Hematocrit 
Mean erythrocyte volume 
Mean amount of HGB in 1 Ery
Mean HGB concentration in Ery 
Erythrocyte distribution width 
Mean Platelet Volume 
Platelet Distribution Width 
Platelet Hematocrit 

Hematopoiesis status

PREMIUM

Glycated hemoglobin 
Estimated Average Blood Glucose

Glucose
metabolism

Uric acid

Risk of gout

PREMIUM
OPTIMAL

Urea
Creatinine
Estimation of glomerular filtration rate

Kidney function

PREMIUM

Total protein
Albumin

State of proteosynthesis

PREMIUM

Total bilirubin
Conjugated bilirubin
ALT
AST
GGT
ALP

Liver and biliary
function

PREMIUM

AMS

Pancreas function

PREMIUM

Trend analysis 
from screening*

*Part of the OPTIMAL and PREMIUM packages 
Requires data from at least two screenings

You can track the results
of the interim screenings
and their development over time
in your NXTM Board.

Comparative 
analyses

Soon

Vitamins and hormones 
Fatty acid profile (lipidomics) 
Amino acids and biogenic amines

The introduction of comparative metabolomics methods in diagnostic practice will bring completely new possibilities for analysis.

*

*min. number of CryoCapsules™ required

Preventive 
screening*

Each sample taken undergoes either basic or extended analysis, where we test key functions of vital organs such as the liver, kidneys, pancreas, and heart.

*Part of the OPTIMAL and PREMIUM packages

We are already able to offer advanced diagnostic methods. Some are available in the plans when the sample is taken, others you need back-to-back years of data to compare.

06/2024

Currently available analyses

* min. number of CryoCapsule™ for implementation

What health risks can be prevented?

  • Disease conditions caused by unhealthy habits and lifestyle

    • Metabolic syndrome

    • Type 2 diabetes mellitus

    • Diseases of the heart and blood vessels

      • Hypertension

      • Atherosclerosis

      • Myocardial infarction

      • Stroke

  • Negative manifestations of aging that can be significantly suppressed or delayed

    • Chronic inflammatory state ("inflamaging", tissue senescence)

    • Deterioration of cognitive functions and memory 

    • Dementia 

    • Macular degeneration of the retina

    • Diseases of the musculoskeletal system (spine pain, arthrosis)

  • Diseases caused by the uncontrolled and autonomous reproduction of body cells, the risk of which is significantly related to smoking, inappropriate nutrition and environmental pollution

     

    • Colon tumors

    • Breast tumors

    • Prostate tumors

    • Lung tumors

  • Diseases associated with improper function of the immune system

    • Autoimmune inflammatory diseases

    • Allergy

    • Immunodeficiency

  • Diseases with congenital disposition and late onset of symptoms

    • Huntington's disease

    • Some forms of Parkinson's disease

    • Some forms of schizophrenia

  • Adverse effects of the surrounding environment on individuals, especially cumulative exposure to ecologically significant pollutants of anthropogenic origin

    • Heavy metals

    • Pesticides, herbicides

    • Plasticizers 

    • Mycotoxins

BLOODCLOUD™ 
RECOMMENDED BY LEADING EXPERTS

A leading Czech molecular immunologist and university professor, holder of prestigious awards for contributions in the field of science and medicine, including the Presidential Medal of Merit and the National Prize Czech Brains.

Prof. RNDr. Václav Hořejší, CSc.

PROFESSOR OF IMMUNOLOGY, NEXTEOM® SCIENTIFIC CONSULTANT

An expert in clinical biochemistry, a long-term head teacher and head of leading Czech hospital laboratories. He specializes in process management, digitization, automation and implementation of modern procedures in clinical laboratories.

Jan Špička, MD, MBA, EuSpLM

LABORATORY HEAD AND FOUNDER OF NEXTEOM®

Biochemist with a focus on biomedical engineering and practical applications of research and development results. Co-founder of several companies operating in the field of healthcare and biotechnology.

Mgr. Ing. Jiří Špička, MBA

CEO AND FOUNDER OF NEXTEOM®

Manager with extensive experience in managing international projects, product development and production. He primarily focuses on strategic planning and is in charge of developing and implementing a business strategy oriented towards B2B partners.

Mgr. Jan Špindler, MBA

DIRECTOR OF THE ENVIRONMENTAL SECTION AND FOUNDER OF NEXTEOM®

Molecular geneticist and leading scientists in gene function analysis in world-wide research consortium (IMPC); director of the Czech Centre for Phenogenomics, a leading European centre for disease model phenotyping

PD Dr.rer.nat. habil. Radislav Sedláček

NEXTEOM® PARTNER AND SCIENTIFIC CONSULTANT

Data in one place. 
Clearly, safely.

In NXTM BOARD 
you always have an overview of everything, 
regarding your health. 

Instant access 
to your data

Manage health conveniently 
dates of your loved ones.

Advanced management
of the whole family

myNEXTEOM application 
meeting the most modern standards of personal data security. 

The highest security level

Improve your health today and provide your doctor with key data for informed decisions.

Safe sharing 
with your doctor

NXTM BOARD is your safe self-care zone for your 
health results and orders for new analyses.

Constant overview 
about your health data and stored samples

We use years of experience, 
to make technology accessible
to all without distinction

NEXTEOM® is backed by a number of leading experts in the fields of medicine, laboratory diagnostics and digital technologies and data security. Our goal is to turn the most modern scientific discoveries and technologies into a user-friendly and affordable product.


In short, we help science help. To everyone, without distinction.

  • Yes, your samples are safely stored in a cryobank designed for long-term storage of biological samples at a temperature of -196°C under conditions that comply with good manufacturing practice.

  • Your samples - CryoCapsules made for long-term storage of your blood serum samples - are your property.

  • Already at the first collection (for the BloodCloud™ OPTIMAL and PREMIUM variants), we will perform a screening of the collected blood and let you know the results.

    At the second sampling (in a year), we will perform the screening again, compare the results and notify you of any undesirable trends. At the same time, from the second year onwards, you will have the opportunity to measure and compare the values of other biomarkers as well as ecological burdens obtained from the surrounding environment (heavy metals, pesticide and herbicide residues, plastic softeners).

    Measuring these parameters and monitoring their values and trends will allow you to better prevent health risks and complications.

    In the next few years, we will make comparative and non-targeted metabolomics methods available to you, and we will come significantly closer to individualized predictive medicine.

  • BloodCloud is designed to be sampled at annual intervals. We recommend that the subsequent blood collection be carried out within 11-13 months of the previous blood collection. We will always notify you in good time of the need to schedule a subscription.

  • Right now. For the analysis of trends and the deployment of individualized predictive methods, it will be important to have samples available over as long a period of time as possible, so that even small deviations can then be recorded and correctly evaluated, and early warning of emerging risks.

Frequently
asked questions

By sending an email, you agree to the processing of personal data.

Sign up and be the first to know!

What else are we going to do?

bottom of page